Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-20

Clinical Trial Update: Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of APIXaban on brain protection in patients with heart failure and sinus rhythm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Heart Failure, Sinus Rhythm | Phase 2 | Status: UNKNOWN